Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
213.50    0.50 (0.23%)
Bid:
212.00
Ask:
213.50
Spread: 1.50 (0.708%)
Market Cap: £590.15m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

AGM Trading Update

7 May 2026 07:00

RNS Number : 2808D
Morgan Advanced Materials PLC
07 May 2026
 

Press Release

Morgan Advanced Materials plc

7 May 2026

 

AGM Trading Update

Trading in-line; full-year guidance maintained

 

Morgan Advanced Materials plc, the global leader in advanced ceramics and carbon systems for technologically demanding applications, announces a trading update in advance of its 2026 Annual General Meeting being held later today.

Current Trading

During the first quarter, we continued to see broad based order intake stability across the Group's divisions and end-markets. Noting the weak prior year comparator, and as expected, the Group delivered organic constant currency revenue1 growth of 6.2%.

2026 Outlook

Q1 trading was in line with expectations and our full year outlook for 2026 remains unchanged. 

We have not observed any material direct or indirect trading impact from the conflict in the Middle East in Q1, and are responding through pricing to offset inflationary impacts. We will continue to monitor this evolving situation including any further impact from the situation becoming prolonged.

Damien Caby, Chief Executive Officer, commented:

"Our Q1 trading was in line with our expectations and today we reconfirm our full year guidance for 2026. We are making good progress against our strategic priorities, including the strategic review of Thermal Products, and continue to focus on executing at pace against the strategy set out at our December 2025 Capital Markets Day."

 

For further information, please contact:

Richard Armitage, CFO

Morgan Advanced Materials

01753 837 000

Nicholas Frost, Investor Relations

 

 

 

Media enquiries:

Nina Coad

Brunswick

0207 404 5959

 

1'Organic constant currency revenue': Group revenue excluding acquisition, disposal and business exit impacts with the current and prior year results translated at current year average exchange rates

Important notice

This announcement contains forward-looking statements. These statements have been made in good faith based on the information available up to the time of the approval of this announcement. No assurance can be given that these expectations will prove to have been correct. By their nature, forward-looking statements involve risks, uncertainties or assumptions that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. As such, undue reliance should not be placed on forward-looking statements.

The Directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEADSKEEFKEFA
Date   Source Headline
7th Apr 20143:49 pmRNSDirector/PDMR Shareholding
2nd Apr 20145:03 pmRNSAnnual Financial Report
1st Apr 201410:40 amRNSDirector/PDMR Shareholding
31st Mar 20144:21 pmRNSDirector/PDMR Shareholding
28th Mar 201410:14 amRNSDirector/PDMR Shareholding
25th Mar 201411:59 amRNSDirector/PDMR Shareholding
25th Mar 20149:46 amRNSDirector/PDMR Shareholding
24th Mar 20145:05 pmRNSDirector/PDMR Shareholding
3rd Mar 20144:15 pmRNSDirector/PDMR Shareholding
3rd Mar 201412:27 pmRNSDirector/PDMR Shareholding
28th Feb 201412:57 pmRNSDirector/PDMR Shareholding
21st Feb 20142:18 pmRNSDirector/PDMR Shareholding
18th Feb 20149:21 amRNSHolding(s) in Company
13th Feb 20147:00 amRNSFull Year Results
7th Feb 201410:31 amRNSDirectorate Change
16th Dec 201310:42 amRNSBlocklisting Interim Review
10th Dec 20134:54 pmRNSDirector/PDMR Shareholding
9th Dec 201310:40 amRNSDirector/PDMR Shareholding
29th Nov 201311:00 amRNSTotal Voting Rights
21st Nov 20139:00 amRNSCapital Markets Day
20th Nov 20132:29 pmRNSIssue of Equity
14th Nov 20138:54 amRNSHolding(s) in Company
11th Nov 20137:00 amRNSInterim Management Statement
30th Oct 201310:00 amRNSScrip Dividend Price
28th Oct 20134:11 pmRNSHolding(s) in Company
25th Sep 20133:39 pmRNSHolding(s) in Company
12th Sep 20135:14 pmRNSHolding(s) in Company
12th Sep 20134:52 pmRNSHolding(s) in Company
12th Sep 20134:13 pmRNSHolding(s) in Company
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.